
The medicube Age-R Booster Pro is the Beyoncé of beauty tools
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change.
Let's talk skincare gadgets. Because let's face it: we've all been seduced by that sleek ad, the influencer with glass skin, or the promise that this one little device will reverse the effects of binge-watching Netflix under fluorescent lights while eating cheese puffs.
Enter the Age-R Booster Pro — a name that sounds like a spaceship but is specially designed to make your face look like it drinks collagen for breakfast.
As someone who reports on and reviews the best beauty brands for a living, I'm here to tell you that medicube is certainly worth it. Now, its device is beating the same buzzy drum and is on sale for less than $200 for a limited time.
Amazon
This snazzy Korean-made device is marketed as a product to help you 'achieve your glass skin goals with innovative technology' tool. Translation: it uses tiny zaps and heat to wake up your collagen, tighten any sagging skin and lift those brows like a pop diva hitting a high note.
According to medicube, it's the closest you can get to a med spa treatment without leaving your house (and, that's always a plus).
If you're in the mood for a skincare investment, this device feels like unwrapping tech from the future. It's white, sleek, and vaguely resembles something that might take your temperature — or steal your Wi-Fi.
As far as aesthetics go, it checks every box. Just don't expect it to fit neatly in your carry-on unless you travel with a dedicated 'skincare gadgets only' suitcase (no judgment if you do).
How it works
No goopy gel? Count me in. The medicube Age-R Booster Pro combines electroporation, microcurrent, EMS, electric needles, LED light therapy and sonic vibration into a single device. It's like having a facialist, dermatologist and spa therapist all rolled into one — without the hefty price tag or awkward small talk.
Each of the four modes is designed to target specific skin concerns with precision. The Air Shot mode uses electric needles to refine pores and combat acne, while the Booster mode employs electroporation to enhance product absorption and brighten your complexion.
Its Microcurrent mode stimulates collagen production for a lifted, youthful appearance, and the Derma Shot mode utilizes EMS to tone and firm facial muscles. Not to mention, tthe device features five LED light settings — blue, orange, green, red and purple — each tailored to address different skin issues, from acne to dullness to elasticity.
The device boasts a skin-contact sensor that activates LED light only when it touches your skin, ensuring safe and effective treatment. It also includes a built-in timer and voice guide to keep you on track during your skincare session. For those seeking a more personalized experience, the AGE-R app offers customized treatment plans, progress tracking and expert tips.
Most reviewers say it's like a cozy face sauna. The Ultra Tune comes with five interchangeable heads, each designed to contour around your face like a skincare GPS. Bonus: It makes you feel like a highly-trained beauty assassin on a mission to slay wrinkles.
It's easy to use, and you don't need a special gel. Simply use the Ultra Tune after your skincare products have fully absorbed. It will help boost your skin's radiance and elasticity when used consistently, which is the best part. Pro tip: use the brand's Deep Vita C Capsule Cream that's also on sale for a brightening boost.
People are seeing real results, too. Reviewers have posted everything from 'my cheeks look lifted' to 'I finally have cheekbones and didn't have to contour.' And yes, we're talking after just a few uses. But others say it's more of a 'slow and steady wins the race' situation. TL;DR: This isn't a Disney princess transformation; consistency is key.
Let's not tiptoe around it — this baby, though on sale, is nearly $200 . That's not exactly pocket change. But, compared to repeated spa visits, it's a steal. The real question is: will you actually use it three times a week, or will it become the world's fanciest dust collector? That's up to you to decide.
The bottom line
If you're skincare-obsessed, love a tech-forward approach, or just want to pretend you're giving yourself a facial while watching 'Bridgerton,' this device is for you. If your ideal skincare routine is 'splash water and hope for the best,' maybe skip it.
Honestly? The medicube Age-R Booster Pro brings the science and the sizzle. It's not perfect, it's not cheap, but it works if you commit to using it consistently. It's only worth it if you consider this device like a skincare marriage of sorts, not a fling.
If you're tired of overpriced creams that promise the world and deliver very little, this device is a solid investment. It's bougie. It's bold. It's your new skincare BFF with benefits. Just remember: good skin takes time, tec,h and maybe a little caffeine.
This article was written by Victoria Giardina, New York Post Commerce Journalist & Content Strategist, who has spent countless hours researching, testing hundreds of products and comparing the latest makeup, skincare, hair and beauty items and trends to determine what's truly worth your hard-earned cash. She evaluates formulas, textures, ingredients and more, in addition to consulting medical and industry experts. Some of Victoria's latest conquests include testing the best vitamin C serums on the market, and a rinse-and-repeat review of the best shampoos of 2025. Victoria, who received a beauty industry essentials certification from the Fashion Institute of Technology, has been creating shopping guides for the New York Post since 2021 and previously held positions at Insider Reviews and CNN Underscored.
Looking for a headline-worthy haul? Keep shopping Post Wanted.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Common menopause medication might prevent breast cancer while treating hot flashes
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. Prostate Cancer Drug Now Available To More Patients With Aggressive Form Of Disease This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Read On The Fox News App Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Experimental Women's Cancer Drug Boosts Survival Rates In Notable Study Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Click Here To Sign Up For Our Health Newsletter Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she article source: Common menopause medication might prevent breast cancer while treating hot flashes
Yahoo
8 hours ago
- Yahoo
Victoria's Voice Foundation Marks National Naloxone Awareness Day on June 6 with Special Event on Capitol Hill
Annual Awareness Day Focusing Attention on the Drug Crisis and Importance of Lifesaving Opioid Overdose Reversal Medications was Launched by Victoria's Voice with Support from a Bipartisan Congressional Resolution Over 140 Iconic Buildings and Landmarks Nationwide to Shine Purple in Recognition of Awareness Day WASHINGTON, June 6, 2025 /PRNewswire/ -- Victoria's Voice Foundation marked National Naloxone Awareness Day on June 6 with a special event on Capitol Hill, bringing together families affected by the opioid crisis, advocates, lawmakers, law enforcement and other first responders. The awareness day is a vital time to heighten awareness of the risks of opioid overdoses and the urgency of expanding access to and the use of lifesaving overdose reversal medicines. It was launched in 2023 by Victoria's Voice Foundation with support from a bipartisan congressional resolution recognizing the awareness day annually. Naloxone, commonly sold over the counter under the brand name NARCAN® Nasal Spray, is a critical tool in preventing fatal opioid overdoses – and is credited with helping drive the recent 27% decline in U.S. drug overdose deaths. Naloxone nasal spray helps restore normal breathing in a person experiencing an opioid overdose. It is safe, easy to administer and non-addictive – and designed for use by bystanders and first responders alike. This is crucial because nearly 40% of fatal overdoses occur in the presence of someone else, according to the CDC. "We must continue to expand naloxone awareness, access and use so we can save as many lives as possible from opioid overdose," said Jackie Siegel, who co-founded Victoria's Voice with her late husband, David, after losing their daughter, Victoria, 18, to an accidental drug overdose on June 6, 2015. On the day she died, Victoria had a pulse when first responders arrived and found her unresponsive, but they were not equipped with naloxone, and Victoria became another statistic. Jackie added: "I am deeply grateful to the members of the U.S. Senate who introduced a bipartisan resolution declaring June 6 as National Naloxone Awareness Day – and to all those on the front lines of the crisis. While today is especially bittersweet as we mark 10 years since Victoria's passing, I find comfort and strength in knowing that her legacy is that because of her death, many more people will live." Victoria's Voice is dedicated to drug awareness and prevention and saving lives from overdose. Since its founding, Victoria's Voice has positively impacted over 1.5 million children and parents through its education programs. Additionally, David Siegel was at the forefront of the efforts to increase naloxone access and use – especially among law enforcement in Florida and nationwide – and inform about its lifesaving power. The 2025 federal resolution was introduced by U.S. Senators Rick Scott (R-FL), Ed Markey (D-MA), Jim Justice (R-WV), Maria Cantwell (D-WA), Ashley Moody (R-FL), Sheldon Whitehouse (D-RI), James Lankford (R-OK), Ron Wyden (D-OR), Angus King (I-ME) and Raphael Warnock (D-GA). Speakers at yesterday's resolution ceremony in the Hart Senate Office Building included Jackie Siegel, Sen. Rick Scott (R-FL), and Seminole County (FL) Sheriff Dennis Lemma, a statewide and national leader on responding to and preventing overdoses, and a Victoria's Voice board member. Other speakers included Sen. Ashley Moody (R-Fl), Rep. Sharice Davids (D-KS), Virginia First Lady Suzanne S. Youngkin, and Sir Edwards, Mayor-President of Baton Rouge (LA). "It is a privilege to join Victoria's Voice Foundation in recognizing National Naloxone Day and honor the life of Victoria, a young life lost to the devastating opioid epidemic. It is every parent's worst nightmare to lose their child, and it is remarkable to see how the Siegel family has turned their grief into a mission to educate others about the dangers of the opioid crisis so other families don't experience this same heartbreak," said Sen. Rick Scott (R-FL). Scott added: "This year was also the first Naloxone Awareness Day since the passing of my friend and Victoria's Voice founder, David Seigel. Ann and I were honored to donate a portion of my Senate salary to Victoria's Voice to support its cause and pay tribute to David's incredible work and legacy. I am proud to work with the foundation to raise awareness on the crisis and life-saving tool of Naloxone, which is critical in our fight to stop loss of life from opioids." "In every state, there are families, friends, and neighbors who are grieving the loss of a loved one to overdose. Naloxone can save lives but only if we get this lifesaving medication in people's hands. We need people to have access to naloxone, be able to afford it, and know how to use it," said Senator Ed Markey (D-MA). "I'm proud to join my colleagues in recognizing June 6 as Naloxone Awareness Day. This is an essential step in spreading awareness and giving communities the tools they need to save lives in the face of the opioid epidemic." National Naloxone Awareness Day is proudly sponsored by Emergent BioSolutions, the makers of NARCAN® Nasal Spray. "On National Naloxone Awareness Day, we have the opportunity to reinforce opioid emergency preparedness and make sure stakeholders across all sectors – from government officials to business leaders and local organizations – feel equipped with the tools they need to be ready to rescue not only today, but every day," stated Paul Williams, senior vice president, head of products business, global government & public affairs at Emergent. "We're proud of the work Victoria's Voice Foundation is doing year-round and we're honored to use this key moment in time to raise awareness and keep our communities safe together." In support of National Naloxone Awareness Day, over 140 iconic buildings, landmarks, bridges, monuments, parks, museums, city halls, downtown hubs and skylines nationwide will glow purple. From Niagara Falls, Baltimore's City Hall Dome, and the Kia Center in Victoria's Voice's Orlando hometown, to the Louisiana State Capitol, Chicago's 875 North Michigan Avenue and the Hawaii Convention Center, lights will be illuminated purple in a powerful display of awareness, unity and hope. Additionally, proclamations were issued by counties, cities and states including Orange County (FL), Baltimore, Kansas City, and the State of Illinois. For more information about National Naloxone Awareness Day, visit About Victoria's Voice Foundation David and Jackie Siegel established Victoria's Voice Foundation after losing their 18-year-old daughter to an accidental drug overdose on June 6, 2015. Victoria's Voice is dedicated to providing support and resources to families affected by substance use. Since its founding, Victoria's Voice has positively impacted over 1.5 million parents and children through its education programs. For more information, visit or @victoriasvoicefoundation. #VictoriasVoiceFoundation #GetGiveSave. About NARCAN® Nasal SprayNARCAN® Naloxone HC1 Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed. View original content: SOURCE Victoria's Voice Foundation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNET
11 hours ago
- CNET
Breathe Easy This Allergy Season With 50% Off a Morento Air Purifier
Springtime is rough for a lot of us with all manner of plant life shooting pollen into the air with reckless abandon. But a good air purifier can help keep allergies at bay, at least within the safety of your own home, and right now you can get your hands on the Morento air purifier while it's 50% off at Amazon. That means it's down to just $80, and it's a great way to clear that air up. Make sure you act fast if you want it though, as there's no telling how long this deal will last. The Morento air purifier -- full name Morento HY4866-WF -- can handle rooms up to 1,076 square feet, which is going to be enough for most bedrooms or living rooms. Along with that, it has an air quality display to help you see how well it's doing, and it even comes with a couple of extra filters. That's just good news for general usability, because we all forget to order new ones the first time around. The result of all of this is that you can get rid of pollutants and allergens in the air, and that can help immensely when you're in the middle of allergy season, or if you've got pets you're suffering with a bit. Hey, did you know? CNET Deals texts are free, easy and save you money. In addition to being generally good at clearing the air, it's also smart, meaning you can control it with Alexa, Google Assistant or the accompanying app so that you can turn it on or off without having to get up or set it to run on a schedule that suits you. Given the power and functionality of this device, not to mention the discount, there's no denying that this is one of the best air purifier deals going on right now. Just make sure you act fast to avoid missing out on it. Why this deal matters A solid air purifier can actually improve some peoples' quality of life a fair bit. The ability to take out things like smoke is good, but the real winner here for many of us is the ability to filter out allergens like pollen and dust. Hayfever season is in full swing at the moment, so being able to save 50% on breathing properly is a great deal.